MRIGlobal is supporting pre-clinical drug development for the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS)
Within NCATS, the Division of Pre-Clinical Innovation plans and conducts advanced collaborative research projects across the pre-clinical phases of translational science.
MRIGlobal will supply services related to synthesis and analysis of small molecules, and will provide support for manufacture and analysis of small molecules; process chemistry optimization; API (active pharmaceutical ingredients) characterization; analytical method validation; and controlled stability studies.